Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $527000.0.

  • Pyxis Oncology's Depreciation & Amortization (CF) fell 2790.7% to $527000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is 5474.83% up from last year.
  • Per Pyxis Oncology's latest filing, its Depreciation & Amortization (CF) stood at $527000.0 for Q3 2025, which was down 2790.7% from $535000.0 recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Depreciation & Amortization (CF) peaked at $1.1 million during Q1 2024, and registered a low of $527000.0 during Q3 2025.